---
title: "Monopar names Jeffrey D. Kent executive vice president, head of medical affairs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296352514.md"
description: "Monopar Therapeutics has appointed Jeffrey D. Kent as Executive Vice President and Head of Medical Affairs, effective September 1, 2026. His role focuses on preparing medical affairs ahead of a potential U.S. FDA decision on the ALXN1840 New Drug Application for Wilson disease. Kent previously served as Chief Medical Officer at Sling Therapeutics and held senior roles at Horizon Therapeutics, Abbott Laboratories, and Searle/Pharmacia."
datetime: "2026-08-19T12:03:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296352514.md)
  - [en](https://longbridge.com/en/news/296352514.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296352514.md)
generator: "portal-rs"
---

# Monopar names Jeffrey D. Kent executive vice president, head of medical affairs

-   Monopar named Jeffrey D. Kent as executive vice president, head of medical affairs, effective Sept. 1, 2026. \* Role centers on building medical affairs ahead of a potential U.S. FDA decision on the ALXN1840 NDA for Wilson disease. \* Kent was chief medical officer at Sling Therapeutics, leading a Phase 2b program for linsitinib in thyroid eye disease. \* He previously held senior medical affairs roles at Horizon Therapeutics, Abbott Laboratories, and Searle/Pharmacia. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monopar Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608190800PRIMZONEFULLFEED9812449) on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [MNPR.US](https://longbridge.com/en/quote/MNPR.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/298045178.md)
- [REG - Barclays PLC Adv Medical Solutns. - Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC](https://longbridge.com/en/news/298035944.md)
- [REG - BlackRock Group Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc](https://longbridge.com/en/news/297929095.md)
- [Rapid Micro Biosystems to present at Sidoti Small-Cap Virtual Conference](https://longbridge.com/en/news/298071394.md)
- [12:20 ETMemorialCare Rehabilitation Institute at Long Beach Medical Center Earns Exemplary Three-Year CARF Accreditation for Eighth Consecutive Time](https://longbridge.com/en/news/297939929.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**